FLT3 and acute myeloid leukemia: The growth enhancement showed no significant association with AML cell differentiation (morphology according to FAB classification, CD34 expression), karyotype (favorable/intermediate/adverse/normal), or Flt3/NPM1 mutations (data not shown).